Showing 241-260 of 8668 for: Cochrane Systematic Reviews Back
- Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
Cochrane Systematic Reviews, 11-Jul-2011
Osteoporosis is an abnormal reduction in bone mass and bone deterioration leading to increased fracture risk. Alendronate belongs to the bisphosphonate class of drugs, which act to inhibit bone resorption by interfering with the activity of osteoclasts.
- Alexander technique for chronic asthma
Cochrane Systematic Reviews, 12-Sep-2012
'The Alexander technique' is a taught form of therapy involving a series of movements designed to correct posture and bring the body into natural alignment with the object of helping it to function efficiently, and is reported to aid relaxation. Some prac
- Alginate dressings for healing diabetic foot ulcers
Cochrane Systematic Reviews, 25-Jun-2013
Foot ulcers in people with diabetes mellitus are a common and serious global health issue. Dressings form a key part of ulcer treatment, with clinicians and patients having many different types to choose from including alginate dressings. A clear and curr
- Alginate dressings for treating pressure ulcers
Cochrane Systematic Reviews, 18-May-2015
Pressure ulcers, also known as bedsores, decubitus ulcers and pressure injuries, are localised areas of injury to the skin or the underlying tissue, or both. Dressings are widely used to treat pressure ulcers and there are many options to choose from incl
- Alginate dressings for venous leg ulcers
Cochrane Systematic Reviews, 19-Aug-2015
Venous leg ulcers are a common and recurring type of chronic, complex wound associated with considerable cost to patients and healthcare providers. To aid healing, primary wound contact dressings are usually applied to ulcers beneath compression devices.
- Alkalinisation for organophosphorus pesticide poisoning
Cochrane Systematic Reviews, 9-Nov-2010
Poisoning with organophosphorus pesticides (OPs) is an important cause of morbidity and mortality worldwide, particularly in developing countries. The case-fatality for intentional self-poisoning is around 10 to 20% even when the standard antidotes (atrop
- Alkylating agents for Waldenstrom's macroglobulinaemia
Cochrane Systematic Reviews, 21-Jan-2009
Waldenstrom's macroglobulinaemia (WM) is an uncommon B-cell lymphoproliferative disorder characterized by bone marrow infiltration and production of monoclonal immunoglobulin. Uncertainty remains if alkylating agents, such as chlorambucil, melphalan or cy
- Allergen injection immunotherapy for seasonal allergic rhinitis
Cochrane Systematic Reviews, 24-Jan-2007
Allergic rhinitis is the most common of the allergic diseases. Despite improved understanding of the pathophysiology of allergic rhinitis and advances in its pharmacological treatment, its prevalence has increased worldwide. For patients whose symptoms re
- Allergen-specific oral immunotherapy for peanut allergy
Cochrane Systematic Reviews, 14-Aug-2012
Peanut allergy is one of the most common forms of food allergy encountered in clinical practice. In most cases, it does not spontaneously resolve; furthermore, it is frequently implicated in acute life-threatening reactions. The current management of pea
- Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission
Cochrane Systematic Reviews, 9-Aug-2011
Consolidation chemotherapy, autologous hematopoietic cell transplantation (HCT) and allogeneic HCT represent potential treatment alternatives for post-remission therapy in adult acute lymphoblastic leukemia (ALL), but there is genuine uncertainty regardin
- Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma
Cochrane Systematic Reviews, 29-Aug-2013
Primary cutaneous T-cell lymphomas (CTCL) belong to the group of non-Hodgkin lymphomas and usually run an indolent course. However, some patients progress to advanced tumour or leukaemic stages. To date, there is no cure for those cases. In the last few y
- Allopurinol for chronic gout
Cochrane Systematic Reviews, 17-Sep-2014
Allopurinol, a xanthine oxidase inhibitor, is considered one of the most effective urate-lowering drugs and is frequently used in the treatment of chronic gout.
- Allopurinol for chronic prostatitis
Cochrane Systematic Reviews, 21-Oct-2002
Chronic prostatitis is a condition that causes men substantial morbidity through the associated constellation of urinary symptoms, sexual dysfunction, and pelvic pain. The etiology of chronic prostatitis is unknown, and the many and varied treatments for
- Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic‐ischaemic encephalopathy
Cochrane Systematic Reviews, 11-Jul-2012
Delayed neuronal death following a perinatal hypoxic insult is due partly to xanthine oxidase-mediated production of cytotoxic free radicals. Evidence exists that allopurinol, a xanthine-oxidase inhibitor, reduces delayed cell death in experimental models
- Almitrine-Raubasine combination for dementia
Cochrane Systematic Reviews, 15-Feb-2011
Almitrine-raubasine combination (brand name Duxil), has been considered as an alternative treatment for dementia.
- Aloe vera for prevention and treatment of infusion phlebitis
Cochrane Systematic Reviews, 31-Mar-2017
Up to 80% of hospitalised patients receive intravenous therapy at some point during their admission. About 20% to 70% of patients receiving intravenous therapy develop phlebitis. Infusion phlebitis has become one of the most common complications in patien
- Aloe vera for treating acute and chronic wounds
Cochrane Systematic Reviews, 28-Dec-2011
Aloe vera is a cactus-like perennial succulent belonging to the Liliaceae Family that is commonly grown in tropical climates. Animal studies have suggested that Aloe vera may help accelerate the wound healing process.
- Alpha lipoic acid for dementia
Cochrane Systematic Reviews, 26-Jan-2004
Oxidative processes have been implicated in the pathogenesis of neurodegenerative dementias including Alzheimer's disease. Protecting the central nervous system against these damaging mechanisms may be a useful therapeutic approach. Alpha lipoic acid (ALA
- Alpha‐1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants
Cochrane Systematic Reviews, 23-Jul-2001
Inflammation of the pulmonary parenchyma is one of the important mechanisms implicated in development of chronic lung disease (CLD) in preterm neonates.
- Alpha‐2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery
Cochrane Systematic Reviews, 6-Mar-2018
The surgical stress response plays an important role on the pathogenesis of perioperative cardiac complications. Alpha-2 adrenergic agonists attenuate this response and may help prevent postoperative cardiac complications.
